Loading…
CIK 0001388551 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("caxton-corp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | $357K | 8.3%Prev: 1.4% | 710 SH | Increased+59 SH |
| COMPASS THERAPEUTICS INC | COM | $158K | 3.7%Prev: 0.8% | 29,495 SH | Decreased-24,008 SH |
| CONTEXT THERAPEUTICS INC | COM | $27K | 0.6%Prev: 0.1% | 18,403 SH | Increased |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $58K | 1.4%Prev: 0.1% | 28,453 SH | Increased+12,060 SH |
| KYVERNA THERAPEUTICS INC | COM | $176K | 4.1%Prev: 0.6% | 18,773 SH | Increased-4,208 SH |
| LEXEO THERAPEUTICS INC | COM | $138K | 3.2%Prev: 0.5% | 13,943 SH | Increased-3,389 SH |
| MIND MEDICINE MINDMED INC | COM NEW | $210K | 4.9%Prev: 1.4% | 15,688 SH | Decreased-11,323 SH |
| SAB BIOTHERAPEUTICS INC | COM NEW | $39K | 0.9%Prev: 0.1% | 10,527 SH | Increased-408 SH |
| SPDR GOLD TR | GOLD SHS | $2.8M | 64.5%Prev: 11.3% | 6,964 SH | Increased-322 SH |
| SPYRE THERAPEUTICS INC | COM NEW | $292K | 6.8% | 8,919 SH | New |
| X4 PHARMACEUTICALS INC | COM NEW | $62K | 1.5% | 15,557 SH | New |
| 13F-HR |
| 0000919574-26-005174 |
| $1.9M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000919574-25-004762 | $9.9M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0000919574-26-003017 | $4.0M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000919574-25-003127 | $5.1M | View |